FDCNSE:FDC -0.57%85 Interest Coverage is 59.50 as of Mar. 2026, which is 34% below its 10-year median of 89.80. GuruFocus rates NSE:FDC with a GF Score™ of 85/100 and a GF Value™ of ₹479.74 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 684 Drug Manufacturers companies, FDC ranks better than 72.81% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. FDC's
Operating Income
for the
three
months ended in Mar. 2026 was ₹920 Mil. FDC's Interest Expense for the
three
months ended in Mar. 2026 was ₹-15 Mil.
FDC's interest coverage for the quarter that ended in Mar. 2026 was 59.50.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. FDC Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for FDC's Interest Coverage or its related term are showing as below:
NSE:FDC'
s Interest Coverage Range Over the Past 10 Years
Min: 54.87 Med: 89.8 Max: 211.04
Current: 54.87
NSE:FDC's Interest Coverage is ranked better than 72.81% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs NSE:FDC: 54.87
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
FDC Interest Coverage Related Terms
FDC Interest Coverage Historical Data
* Premium members only.
The historical data trend for FDC's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, FDC's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
FDC Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, FDC's Interest Coverage distribution charts can be found below:
* The bar in red indicates where FDC's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FDC (NSE:FDC) has a Interest Coverage of 59.50 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on FDC and its competitors. This is 34% below median its historical median of 89.80. Over the past decade, FDC's Interest Coverage has ranged from 54.87 to 211.04. According to the industry distribution chart, FDC ranks #186 out of 684 companies in the Drug Manufacturers industry, placing it in the top 27.2%.
Is FDC's Interest Coverage too high?
FDC's current Interest Coverage of 59.50 is 34% below median its 10-year median of 89.80. Over the past 10 years, this metric has ranged from a low of 54.87 to a high of 211.04. The Drug Manufacturers industry median Interest Coverage is 12.77. FDC's value of 59.50 is 366.1% above this industry median. Based on the distribution chart, FDC ranks #186 out of 684 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, FDC has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does FDC's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, FDC ranks #186 out of 684 companies for Interest Coverage. This puts FDC in the upper half of its industry. The industry median Interest Coverage is 12.77. FDC's value of 59.50 is 366.1% above this benchmark. Historically, FDC's own Interest Coverage has ranged from 54.87 to 211.04 over the past decade. While the company's 10-year median is 89.80 vs. the industry median of 12.77, FDC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. FDC's current Interest Coverage of 59.50 is 366.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on FDC and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FDC's current Interest Coverage is 59.50, which is 34% below median its own 10-year median of 89.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FDC stock overvalued right now?
Based on GuruFocus' analysis, FDC (NSE:FDC) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹479.74, compared to a current price of ₹408.30 — trading 14.9% below its estimated fair value. The current Interest Coverage is 59.50, which is 34% below median its 10-year median of 89.80 and 366.1% above the Drug Manufacturers industry median of 12.77. FDC's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For FDC (NSE:FDC), the current Interest Coverage is 59.50 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is FDC (NSE:FDC) Overvalued in 2026?
Based on GuruFocus' analysis, FDC stock appears to be undervalued.
The current stock price of ₹408.30 is trading 14.9% below its estimated GF Value™ of ₹479.74.
GuruFocus considers FDC to be Modestly Undervalued.
Key valuation signals for NSE:FDC:
Interest Coverage: 59.50 (34% below median its 10-year median of 89.80)
GF Value™: ₹479.74 vs. price of ₹408.30 (14.9% below fair value)
Industry Position: 366.1% above the Drug Manufacturers median (#186 of 684)
No single metric tells the full story. See the NSE:FDC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
FDC Ltd is principally engaged in the business of manufacturing and trading pharmaceutical products. It has its presence in numerous therapeutic segments including anti-infectives, gastrointestinal treatments, ophthalmics, vitamins, minerals, dietary supplements, cardiovascular solutions, anti-diabetics, and others. The company's different pharmaceutical products are marketed through brands such as Electral, Enerzal, Zifi, Zocon, Vitcofol, Otek Ac Neo, Amodep AT, Simyl MCT Oil, and many others. Geographically, the company derives maximum revenue from India and the rest from the United States of America, and other regions.
85GF Score
Get the complete analysis for NSE:FDC
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:FDC has been successfully added to your 
